Top Suppliers:I want be here



313368-91-1

313368-91-1 structure
313368-91-1 structure
  • Name: ITI-722
  • Chemical Name: Lumateperone
  • CAS Number: 313368-91-1
  • Molecular Formula: C24H28FN3O
  • Molecular Weight: 393.497
  • Catalog: Signaling Pathways GPCR/G Protein 5-HT Receptor
  • Create Date: 2018-09-27 18:03:47
  • Modify Date: 2025-08-21 18:48:01
  • Lumateperone (ITI-007) is a 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki = 32 nM), and a dopamine D1 receptor modulator. Lumateperone has anticancer activity and can also be used in studies of psychiatric disorders such as schizophrenia[1][2][3].

Name Lumateperone
Synonyms Lumateperone
1-(4-Fluorophenyl)-4-[(6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-1-butanone
1-Butanone, 1-(4-fluorophenyl)-4-[(6bR,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-
UNII:70BSQ12069
ITI-007
ITI-722
Description Lumateperone (ITI-007) is a 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki = 32 nM), and a dopamine D1 receptor modulator. Lumateperone has anticancer activity and can also be used in studies of psychiatric disorders such as schizophrenia[1][2][3].
Related Catalog
In Vitro Lumateperone (2-30 μM) has anti-tumor activity and can inhibit cell proliferation in a dose-dependent manner[1]. Cell Proliferation Assay[1] Cell Line: RPMI-8226 cells Concentration: 2-30 μM Incubation Time: 48 hours Result: Inhibited cell growth with the IC50 value of 17.30 μM.
In Vivo Lumateperone (i.p., 1-10 mg/kg) promotes NMDA and AMPA-induced currents in a dopamine D1 receptor-dependent manner and increases the release of dopamine and glutamate in rat mPFC slices[2]. Animal Model: Adult male Sprague-Dawley rats[2] Dosage: 1-10 mg/kg Administration: Intraperitoneal injection Result: Inhibited avoidance response at concentrations of 1, 3 and 10 mg/kg after 20 minutes. Promoted NMDA and AMPA-sensitive currents, also significantly increased dopamine and glutamate release at 10 mg/kg in mPFC cone cells of rat.
References

[1]. Jinyuan Zhang, et al. Identification of Trovafloxacin, Ozanimod, and Ozenoxacin as Potent c-Myc G-quadruplex Stabilizers to Suppress c-Myc Transcription and Myeloma Growth. Mol Inform. 2022 Mar 30:e2200011.

[2]. J Titulaer, et al. Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism. Eur Neuropsychopharmacol. 2022 Jul 22;62:22-35.

[3]. Lumateperone

Density 1.3±0.0 g/cm3
Boiling Point 556.4±0.0 °C at 760 mmHg
Molecular Formula C24H28FN3O
Molecular Weight 393.497
Flash Point 290.3±0.0 °C
Exact Mass 393.221649
LogP 3.39
Vapour Pressure 0.0±0.0 mmHg at 25°C
Index of Refraction 1.646
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.